SavedAdd your journal

Journals / Journal of Istanbul Veterinary Sciences / 2026 / Cilt: 10 Sayı: 1

Bromelain: Biological Activities and Therapeutic Potential

Şeyma Nur Yol(İSTANBUL ÜNİVERSİTESİ-CERRAHPAŞA, LİSANSÜSTÜ EĞİTİM ENSTİTÜSÜ, BİYOKİMYA (DR) (VETERİNER))0009-0006-8376-0006
Feraye Esen Gürsel(İSTANBUL ÜNİVERSİTESİ-CERRAHPAŞA, VETERİNER FAKÜLTESİ, VETERİNER HEKİMLİĞİ TEMEL BİLİMLERİ BÖLÜMÜ, VETERİNERLİK BİYOKİMYASI ANABİLİM DALI, BİYOKİMYA BİLİM DALI)0000-0002-1595-2827
Pages
73–80
Publication Date
2026-04-30
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This review summarizes the reported biological activities of bromelain, highlights evidence relevant to veterinary practice and underscores the need for well‑designed, species‑specific clinical trials to clarify efficacy, safety, optimal dosing and product standardization.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Bromelain is a plant-derived proteolytic enzyme complex obtained primarily from the stem of Ananas comosus.
📊
Key Findings & Data:Beyond its protease activity, bromelain has been reported to modulate multiple biological pathways relevant to inflammation, haemostasis, immunity, tissue repair and host–pathogen interactions.
💡
Conclusion & Impact:This review summarizes the reported biological activities of bromelain, highlights evidence relevant to veterinary practice and underscores the need for well‑designed, species‑specific clinical trials to clarify efficacy, safety, optimal dosing and product standardization.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:bromelain · anti-inflammatory · immunomodulation

Abstract

Bromelain is a plant-derived proteolytic enzyme complex obtained primarily from the stem of Ananas comosus. Beyond its protease activity, bromelain has been reported to modulate multiple biological pathways relevant to inflammation, haemostasis, immunity, tissue repair and host–pathogen interactions. Experimental data indicate that bromelain can downregulate pro-inflammatory mediators and cytokines, with proposed involvement of NF-κB/MAPK-related signalling and reduced expression of inflammatory enzymes, and it has also been associated with anti-oedematous effects linked to the kinin system. Bromelain has additionally been associated with antithrombotic and fibrinolytic actions, including effects on platelet aggregation, clotting times and fibrin(ogen) processing. In cancer‑related models, bromelain has been described as influencing apoptosis, cell‑cycle progression and metastatic behaviours through several signalling pathways Bromelain-based enzymatic debridement has enabled clinical application in wound and burn management through selective eschar removal. Veterinary‑oriented studies, although fewer than those in human medicine, suggest potential applications in inflammatory conditions, digestive disorders, musculoskeletal injuries and perioperative management; however, results are not uniformly positive and study designs, doses and preparations vary widely. This review summarizes the reported biological activities of bromelain, highlights evidence relevant to veterinary practice and underscores the need for well‑designed, species‑specific clinical trials to clarify efficacy, safety, optimal dosing and product standardization.

Özet

Bromelain is a plant-derived proteolytic enzyme complex obtained primarily from the stem of Ananas comosus. Beyond its protease activity, bromelain has been reported to modulate multiple biological pathways relevant to inflammation, haemostasis, immunity, tissue repair and host–pathogen interactions. Experimental data indicate that bromelain can downregulate pro-inflammatory mediators and cytokines, with proposed involvement of NF-κB/MAPK-related signalling and reduced expression of inflammatory enzymes, and it has also been associated with anti-oedematous effects linked to the kinin system. Bromelain has additionally been associated with antithrombotic and fibrinolytic actions, including effects on platelet aggregation, clotting times and fibrin(ogen) processing. In cancer‑related models, bromelain has been described as influencing apoptosis, cell‑cycle progression and metastatic behaviours through several signalling pathways Bromelain-based enzymatic debridement has enabled clinical application in wound and burn management through selective eschar removal. Veterinary‑oriented studies, although fewer than those in human medicine, suggest potential applications in inflammatory conditions, digestive disorders, musculoskeletal injuries and perioperative management; however, results are not uniformly positive and study designs, doses and preparations vary widely. This review summarizes the reported biological activities of bromelain, highlights evidence relevant to veterinary practice and underscores the need for well‑designed, species‑specific clinical trials to clarify efficacy, safety, optimal dosing and product standardization.

🔖

Cite This Article

Yol, Ş. N., Gürsel, F. E. (2026). Bromelain: Biological Activities and Therapeutic Potential. Journal of Istanbul Veterinary Sciences, Cilt: 10 Sayı: 1, 73–80. https://doi.org/10.30704/http-www-jivs-net.1880601

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (34)

  1. Aiyegbusi, A. I., Olabiyi, O. O., Duru, F. I., Noronha, C. C., & Okanlawon, A. O. (2010). Bromelain in the early phase of healing in acute crush Achilles tendon injury. Phytotherapy Research, 24(1), 61–65. https://doi.org/10.1002/ptr.3199
  2. Aiyegbusi, A. I., Olabiyi, O. O., Duru, F. I., Noronha, C. C., & Okanlawon, A. O. (2011). A comparative study of the effects of bromelain and fresh pineapple juice on the early phase of healing in acute crush Achilles tendon injury. Journal of Medicinal Food, 14(4), 348–352. https://doi.org/10.1089/jmf.2010.0078
  3. Atuahene, D., Costale, A., Martello, E., Mannelli, A., Radice, E., Ribaldone, D. G., Chiofalo, B., Stefanon, B., & Meineri, G. (2023). A supplement with bromelain, Lentinula edodes, and quercetin: Antioxidant capacity and effects on morphofunctional and fecal parameters (calprotectin, cortisol, and intestinal fermentation products) in kennel dogs. Veterinary Sciences, 10(8), 486. https://doi.org/10.3390/vetsci10080486
  4. Atuahene, D., Zuniga-Chaves, I., Martello, E., Stefanon, B., Suen, G., Balouei, F., & Meineri, G. (2024). The Canine Gut Health: The Impact of a New Feed Supplement on Microbiota Composition. Animals, 14(8), 1189. https://doi.org/10.3390/ani14081189
  5. Azarkan, M., González, M. M., Esposito, R. C., & Errasti, M. E. (2020). Stem bromelain proteolytic machinery: Study of the effects of its components on fibrin(ogen) and blood coagulation. Protein & Peptide Letters, 27(11), 1159–1170. https://doi.org/10.2174/0929866527666200525163622
  6. Bakare, A. O., & Owoyele, B. V. (2021). Bromelain reduced pro-inflammatory mediators as a common pathway that mediate antinociceptive and anti-anxiety effects in sciatic nerve ligated Wistar rats. Scientific Reports, 11(1), 289. https://doi.org/10.1038/s41598-020-79421-9
  7. Bhui, K., Prasad, S., George, J., & Shukla, Y. (2009). Bromelain inhibits COX-2 expression by blocking the activation of MAPK regulated NF-kappa B against skin tumour-initiation triggering mitochondrial death pathway. Cancer Letters, 282(2), 167–176. https://doi.org/10.1016/j.canlet.2009.03.003
  8. Chaudhary, B., Agarwal, S., & Bist, R. (2018). Invulnerability of bromelain against oxidative degeneration and cholinergic deficits imposed by dichlorvos in mice brains. Frontiers in Biology, 13(1), 56–62. https://doi.org/10.1007/s11515-018-1479-1
  9. Chobotova, K., Vernallis, A. B., & Majid, F. A. A. (2010). Bromelain's activity and potential as an anti-cancer agent: Current evidence and perspectives. Cancer Letters, 290(2), 148–156. https://doi.org/10.1016/j.canlet.2009.08.001
  10. Engwerda, C. R., Andrew, D., Ladhams, A., & Mynott, T. L. (2001). Bromelain modulates T cell and B cell immune responses in vitro and in vivo. Cellular Immunology, 210(1), 66–75. https://doi.org/10.1006/cimm.2001.1807
  11. Felton, G. E. (1980). Fibrinolytic and antithrombotic action of bromelain may eliminate thrombosis in heart patients. Medical Hypotheses, 6(11), 1123–1133. https://doi.org/10.1016/0306-9877(80)90134-6
  12. Gaspani, L., Limiroli, E., Ferrario, P., & Bianchi, M. (2002). In vivo and in vitro effects of bromelain on PGE(2) and SP concentrations in the inflammatory exudate in rats. Pharmacology, 65(2), 83–86. https://doi.org/10.1159/000056191
  13. Gläser, D., & Hilberg, T. (2006). The influence of bromelain on platelet count and platelet activity in vitro. Platelets, 17(1), 37–41. https://doi.org/10.1080/09537100500197489
  14. Hale, L. P., Greer, P. K., Trinh, C. T., & James, C. L. (2005). Proteinase activity and stability of natural bromelain preparations. International Immunopharmacology, 5(4), 783–793. https://doi.org/10.1016/j.intimp.2004.12.007
  15. Hirche, C., Kreken Almeland, S., Dheansa, B., Fuchs, P., Governa, M., Hoeksema, H., Korzeniowski, T., Lumenta, D. B., Marinescu, S., Martinez-Mendez, J. R., Plock, J. A., Sander, F., Ziegler, B., & Kneser, U. (2020). Eschar removal by bromelain-based enzymatic debridement (NexoBrid®) in burns: European consensus guidelines update. Burns, 46(4), 782–796. https://doi.org/10.1016/j.burns.2020.03.002
  16. Huang, J. R., Wu, C. C., Hou, R. C. W., & Jeng, K. C. G. (2008). Bromelain inhibits lipopolysaccharide-induced cytokine production in human THP-1 monocytes via the removal of CD14. Immunological Investigations, 37(4), 263–277. https://doi.org/10.1080/08820130802083622
  17. Juhasz, B., Thirunavukkarasu, M., Pant, R., Zhan, L., Penumathsa, S. V., Secor, E. R., Jr., Srivastava, S., Raychaudhuri, U., Menon, V. P., Otani, H., Thrall, R. S., & Maulik, N. (2008). Bromelain induces cardioprotection against ischemia-reperfusion injury through Akt/FOXO pathway in rat myocardium. American Journal of Physiology-Heart and Circulatory Physiology, 294(3), H1365–H1370. https://doi.org/10.1152/ajpheart.01005.2007
  18. Kaur, H., Corscadden, K., Lott, C., Elbatarny, H. S., & Othman, M. (2016). Bromelain has paradoxical effects on blood coagulability: A study using thromboelastography. Blood Coagulation & Fibrinolysis, 27(7), 745–752. https://doi.org/10.1097/MBC.0000000000000244
  19. Kumakura, S., Yamashita, M., & Tsurufuji, S. (1988). Effect of bromelain on kaolin-induced inflammation in rats. European Journal of Pharmacology, 150(3), 295–301. https://doi.org/10.1016/0014-2999(88)90010-6
  20. Lee, K. W., McKinney, B. H., Blankenship, K. D., & Morris, D. O. (2020). Detection and inhibition of IgE for cross-reactive carbohydrate determinants evident in an enzyme-linked immunosorbent assay for detection of allergen-specific IgE in the sera of dogs and cats. Veterinary Dermatology, 31(6), 439–e116. https://doi.org/10.1111/vde.12904
  21. Marino, G., Pugliese, M., Pecchia, F., Garufi, G., Lupo, V., Di Giorgio, S., & Sfacteria, A. (2021). Conservative treatments for feline fibroadenomatous changes of the mammary gland. Open Veterinary Journal, 11(4), 680–685. https://doi.org/10.5455/OVJ.2021.v11.i4.19
  22. Maurer, H. R. (2001). Bromelain: Biochemistry, pharmacology and medical use. Cellular and Molecular Life Sciences, 58(9), 1234–1245. https://doi.org/10.1007/PL00000936
  23. Murthy, S. S., & Narsaiah, T. B. (2021). Cytotoxic effect of bromelain on HepG2 hepatocellular carcinoma cell line. Applied Biochemistry and Biotechnology, 193(6), 1873–1897. https://doi.org/10.1007/s12010-021-03505-z
  24. Mynott, T. L., Guandalini, S., Raimondi, F., & Fasano, A. (1997). Bromelain prevents secretion caused by Vibrio cholerae and Escherichia coli enterotoxins in rabbit ileum in vitro. Gastroenterology, 113(1), 175–184. https://doi.org/10.1016/S0016-5085(97)70093-3
  25. Pavan, R., Jain, S., Shraddha, & Kumar, A. (2012). Properties and therapeutic application of bromelain: A review. Biotechnology Research International, 2012, 976203. https://doi.org/10.1155/2012/976203
  26. Rathnavelu, V., Alitheen, N. B., Sohila, S., Kanagesan, S., & Ramesh, R. (2016). Potential role of bromelain in clinical and therapeutic applications (Review). Biomedical Reports, 5(3), 283–288. https://doi.org/10.3892/br.2016.720
  27. Ribeiro, M. R., Conceição, M. E. B. A. M., Bezerra, D. K. O., Teles, J. P. P., Giuffrida, R., & Cassu, R. N. (2023). Bromelain does not provide significant analgesic and anti-inflammatory benefits over placebo in cats undergoing ovariohysterectomy. Journal of the American Veterinary Medical Association, 261(9), 1297–1304. https://doi.org/10.2460/javma.23.02.0117
  28. Rosenberg, L., Krieger, Y., Bogdanov-Berezovski, A., Silberstein, E., Shoham, Y., & Singer, A. J. (2014). A novel rapid and selective enzymatic debridement agent for burn wound management: A multi-center RCT. Burns, 40(3), 466–474. https://doi.org/10.1016/j.burns.2013.08.013
  29. Sagar, S., Rathinavel, A. K., Lutz, W. E., Struble, L. R., Khurana, S., Schnaubelt, A. T., Mishra, N. K., Guda, C., Palermo, N. Y., Broadhurst, M. J., Hoffmann, T., Bayles, K. W., Reid, S. P. M., Borgstahl, G. E. O., & Radhakrishnan, P. (2021). Bromelain inhibits SARS-CoV-2 infection via targeting ACE-2, TMPRSS2, and spike protein. Clinical and Translational Medicine, 11(2), e281. https://doi.org/10.1002/ctm2.281
  30. Secor, E. R., Jr., Carson, W. F., IV, Cloutier, M. M., Guernsey, L. A., Schramm, C. M., Wu, C. A., & Thrall, R. S. (2005). Bromelain exerts anti-inflammatory effects in an ovalbumin-induced murine model of allergic airway disease. Cellular Immunology, 237(1), 68–75. https://doi.org/10.1016/j.cellimm.2005.10.002
  31. Secor, E. R., Jr., Singh, A., Guernsey, L. A., McNamara, J. T., Zhan, L., Maulik, N., & Thrall, R. S. (2009). Bromelain treatment reduces CD25 expression on activated CD4+ T cells in vitro. International Immunopharmacology, 9(3), 340–346. https://doi.org/10.1016/j.intimp.2008.12.012
  32. Siengdee, P., Nganvongpanit, K., Pothacharoen, P., Chomdej, S., Mekchay, S., & Ong-Chai, S. (2010). Effects of bromelain on cellular characteristics and expression of selected genes in canine in vitro chondrocyte culture. Veterinarni Medicina, 55(11), 551–560. https://doi.org/10.17221/3012-VETMED
  33. Varilla, C., Marcone, M., Paiva, L., & Baptista, J. (2021). Bromelain, a group of pineapple proteolytic complex enzymes (Ananas comosus) and their possible therapeutic and clinical effects. A summary. Foods, 10(10), 2249. https://doi.org/10.3390/foods10102249
  34. Walker, J. A., Cerny, F. J., Cotter, J. R., & Burton, H. W. (1992). Attenuation of contraction-induced skeletal muscle injury by bromelain. Medicine and Science in Sports and Exercise, 24(1), 20–25.